TFOS

A LIFESTYLE EPIDEMIC: OCULAR SURFACE DISEASE

Retrieved on: 
Tuesday, April 18, 2023

BOSTON, April 18, 2023 /PRNewswire/ -- Today the Tear Film & Ocular Surface Society (TFOS), a world leader in eye health research and education, announced their new global Workshop report, entitled "A Lifestyle Epidemic: Ocular Surface Disease," which will be published this quarter in The Ocular Surface journal.

Key Points: 
  • BOSTON, April 18, 2023 /PRNewswire/ -- Today the Tear Film & Ocular Surface Society (TFOS), a world leader in eye health research and education, announced their new global Workshop report, entitled "A Lifestyle Epidemic: Ocular Surface Disease," which will be published this quarter in The Ocular Surface journal.
  • The World Health Organization indicates that eye problems are increasingly linked to lifestyle choices.1 "Lifestyle defines the way in which a person lives.
  • "This new TFOS Report focuses on the direct and indirect impacts that everyday lifestyle choices and challenges have on ocular surface health – from screen time, to our beauty routines, to our nutrition, to where we live," stated Amy Gallant Sullivan, Executive Director, TFOS.
  • "This TFOS Lifestyle Workshop report involved 158 experts from 38 countries around the world, required almost three years to complete, and was committed to an evidence-based approach and a process of open communication, dialogue and transparency, in order to achieve a consensus concerning lifestyle choices and ocular surface disease," concluded David A. Sullivan, PhD, Founder, TFOS.

A LIFESTYLE EPIDEMIC: OCULAR SURFACE DISEASE

Retrieved on: 
Tuesday, April 18, 2023

BOSTON, April 18, 2023 /PRNewswire/ -- Today the Tear Film & Ocular Surface Society (TFOS), a world leader in eye health research and education, announced their new global Workshop report, entitled "A Lifestyle Epidemic: Ocular Surface Disease," which will be published this quarter in The Ocular Surface journal.

Key Points: 
  • BOSTON, April 18, 2023 /PRNewswire/ -- Today the Tear Film & Ocular Surface Society (TFOS), a world leader in eye health research and education, announced their new global Workshop report, entitled "A Lifestyle Epidemic: Ocular Surface Disease," which will be published this quarter in The Ocular Surface journal.
  • The World Health Organization indicates that eye problems are increasingly linked to lifestyle choices.1 "Lifestyle defines the way in which a person lives.
  • "This new TFOS Report focuses on the direct and indirect impacts that everyday lifestyle choices and challenges have on ocular surface health – from screen time, to our beauty routines, to our nutrition, to where we live," stated Amy Gallant Sullivan, Executive Director, TFOS.
  • "This TFOS Lifestyle Workshop report involved 158 experts from 38 countries around the world, required almost three years to complete, and was committed to an evidence-based approach and a process of open communication, dialogue and transparency, in order to achieve a consensus concerning lifestyle choices and ocular surface disease," concluded David A. Sullivan, PhD, Founder, TFOS.

Alcon to Acquire EYSUVIS Adding to Its Ophthalmic Eye Drop Portfolio

Retrieved on: 
Monday, May 23, 2022

EYSUVIS will complement the Systane family of eye drops which includes the recently launched Systane Preservative-Free formulations now available in a convenient, multi-dose bottle.

Key Points: 
  • EYSUVIS will complement the Systane family of eye drops which includes the recently launched Systane Preservative-Free formulations now available in a convenient, multi-dose bottle.
  • While the Systane family is used for ongoing management of dry eye symptoms, EYSUVIS will provide Eye Care Professionals (ECPs) with an option for short-term treatment to mitigate dry eye disease.
  • We will be pleased to add EYSUVIS to our growing pharmaceutical portfolio, said Sergio Duplan, President, North America at Alcon.
  • EYSUVIS is a natural fit for our newly formed ophthalmic eye drop sales force in the United States.

Alcon Continues Its Successful Rollout of PRECISION1 Daily Disposable Contact Lenses, Now Available in Key Markets Throughout Latin America, Asia & Europe

Retrieved on: 
Wednesday, December 15, 2021

The spherical lens is now available in key markets throughout Latin America and Asia, and PRECISION1 for Astigmatism is available in markets throughout Europe.

Key Points: 
  • The spherical lens is now available in key markets throughout Latin America and Asia, and PRECISION1 for Astigmatism is available in markets throughout Europe.
  • Inspired from the water gradient lens material in DAILIES TOTAL1, PRECISION1 is the first-and-only contact lens with Alcons proprietary SMARTSURFACE Technology.
  • *
    The launch of PRECISION1 for Astigmatism provides a significant opportunity to attract new contact lens wearers.
  • A Survey of contact lens wearers and eye care professionals on satisfaction with a new smartsurface silicone hydrogel daily disposable contact lens.

New treatment for severe corneal inflammation from DED now listed on PBS

Retrieved on: 
Thursday, September 30, 2021

(8,9)

Key Points: 
  • (8,9)
    MELBOURNE, Oct 1, 2021 - (ACN Newswire) - Today, adults living with severe corneal inflammation from DED (dry eye disease) gain access to a new treatment on the PBS.
  • Ikervis(R), Australia's first PBS listed disease-modifying ciclosporin eye drop treatment for severe keratitis in adults with DED, is now available (October 1, 2021).
  • "Artificial tears aim to provide symptom relief for DED, but don't address the underlying cause of severe corneal inflammation.
  • Executive Chair of The B Team Australasia, Lynette has spent the past 16 years living with severe corneal inflammation from DED.

TJ Nutrition® Announces Four Esteemed Professionals to Join Advisory Board

Retrieved on: 
Thursday, September 9, 2021

As a patient of POTS Care, PLLC who has benefited from the support of TJ Nutrition products, Jesse has a personal connection to the work of TJ Nutrition.

Key Points: 
  • As a patient of POTS Care, PLLC who has benefited from the support of TJ Nutrition products, Jesse has a personal connection to the work of TJ Nutrition.
  • "I'm thrilled to serve on the medical advisory board for TJ Nutrition," Dr. Karpecki said.
  • The Advisory Board for TJ Nutrition will help disseminate this new knowledge and teach others how this approach can be dovetailed into their current evaluation and treatment regimen for dry eye.
  • TJ Nutrition is now at the forefront of unique, patented supplements based on her research through Genetic Disease Investigators.

A Lifestyle Epidemic: Ocular Surface Disease

Retrieved on: 
Wednesday, December 9, 2020

BOSTON, Dec. 9, 2020 /PRNewswire/ -- Today the Tear Film & Ocular Surface Society (TFOS), a world leader in eye health research and education, announced their next global Workshop, entitled "A Lifestyle Epidemic: Ocular Surface Disease."

Key Points: 
  • BOSTON, Dec. 9, 2020 /PRNewswire/ -- Today the Tear Film & Ocular Surface Society (TFOS), a world leader in eye health research and education, announced their next global Workshop, entitled "A Lifestyle Epidemic: Ocular Surface Disease."
  • The World Health Organization indicates that eye problems are increasingly linked to lifestyle choices.
  • "The study of ocular surface disease has evolved dramatically in the last years and TFOS has played an instrumental role in this transformation," explained Dr. Jennifer Craig, Associate Professor and Head of the Ocular Surface Laboratory at the University of Auckland in New Zealand.
  • Founded in 2000, the Tear Film & Ocular Surface Society is a world leader in eye health education headquartered in Boston, USA.

A Lifestyle Epidemic: Ocular Surface Disease

Retrieved on: 
Wednesday, December 9, 2020

BOSTON, Dec. 9, 2020 /PRNewswire/ -- Today the Tear Film & Ocular Surface Society (TFOS), a world leader in eye health research and education, announced their next global Workshop, entitled "A Lifestyle Epidemic: Ocular Surface Disease."

Key Points: 
  • BOSTON, Dec. 9, 2020 /PRNewswire/ -- Today the Tear Film & Ocular Surface Society (TFOS), a world leader in eye health research and education, announced their next global Workshop, entitled "A Lifestyle Epidemic: Ocular Surface Disease."
  • The World Health Organization indicates that eye problems are increasingly linked to lifestyle choices.
  • "The study of ocular surface disease has evolved dramatically in the last years and TFOS has played an instrumental role in this transformation," explained Dr. Jennifer Craig, Associate Professor and Head of the Ocular Surface Laboratory at the University of Auckland in New Zealand.
  • Founded in 2000, the Tear Film & Ocular Surface Society is a world leader in eye health education headquartered in Boston, USA.